11 Sep 2023 | 09:40 am | 1 min. read
Multinational law firm Pinsent Masons has hired transactional life sciences specialist Michael Stewart as partner in its Dublin office as it expands its pan-European Technology, Science and Industry (TSI) capabilities.
Michael is a leading life sciences lawyer, specialising in corporate transactional projects including M&A, assets sales and purchases, corporate finance and licensing and collaboration deals.
Joining from Novartis, where he was most recently Lead Counsel in the group transactions team, Michael previously held roles as Global Head of Legal Strategic Transactions & Established Medicines in the company’s pharmaceuticals division and senior counsel in the Group M&A team.
Michael is the fifth partner to join the firm’s TSI sector this year following IP life sciences expert Kristina Cornish, data and information law partner Jaya Handa, TMT cyber specialist Eleanor Ludlam and patent litigator James Marshall.
Head of IP and Life Sciences at Pinsent Masons, Clare Tunstall, said: “Michael has acted on some of the biggest transactions in the sector. His in-house and private practice expertise will have a significant impact on our multinational life sciences capabilities and in particular will enhance our on the ground sector offering in Dublin.
“High growth biotech and medtech start-ups play a pivotal role in the pharmaceuticals industry and we are confident that Michael’s expertise will enable us to further tap into this vibrant market.”
During his time at Novartis, Michael worked on major transactions including the spin-off by Novartis of Alcon (its eye care division), the acquisition by Sandoz of the Japan based generics business of Aspen Pharmacare Holdings and most recently, the announced sale by Novartis of Xiidra (a product for the treatment of dry eye disease) to Bausch + Lomb.
Commenting on his move Michael said: “After seven years in-house I am very excited to move back to private practice and continue my career at Pinsent Masons. The firm’s reputation as a leader in life sciences legal services, its stellar client base and depth of expertise will be an excellent platform that will enable me to build a thriving cross border practice.”
Multinational law firm Pinsent Masons has advised Southeast Asia-based clean energy developer Alba Renewables on its acquisition by a leading global investment firm.
Multinational law firm Pinsent Masons has advised the Aviva Group on the successful High Court-sanctioned transfer of the entire insurance business of Aviva Protection UK Limited (formerly AIG Life) to Aviva Life & Pensions UK Limited, under a Part VII insurance business transfer scheme.
Multinational law firm Pinsent Masons has announced today that it has been named as a supplier on Crown Commercial Service’s Legal Panel for Government framework on Lot 2- Major Project and Complex Advice.
Multinational law firm Pinsent Masons has advised Southeast Asia-based clean energy developer Alba Renewables on its acquisition by a leading global investment firm.
Multinational law firm Pinsent Masons has advised Great British Energy (“GBE”), the National Wealth Fund (“NWF”) and the Scottish National Investment Bank (“SNIB”) on their acquisition of a stake in Pentland Offshore Wind Farm from Copenhagen Infrastructure Partners (“CIP”) and agreed to provide an aggregate investment of up to £150,000,000 in the project.
Multinational law firm Pinsent Masons has advised Swiss-based Ufenau Capital Partners on its investment in Express Solicitors, a fast-growing UK personal injury law firm.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]
